Medical solutions company focused on mental illnesses and disorders with emphasis on psychedelics medicine Champignon Brands Inc. (CNSX: SHRM) (OTCQB: SHRMF) announced a cease trade order having been revoked by the Ontario Securities Commission and the British Columbia Securities Commission.
This revocation of the cease trade orders against the company was done on April 22. Of course this comes as good news for the Canada based company. The company’s common shares ceased trading on CSE after the company failed to provide periodic disclosure for interim period ended on June 30, 2020.
The two commissions issued the cease trading orders after failure to make the disclosure however following this revocation, shares of the company will now resume trading on the CSE with immediate effect.
The company’s Chairman and Chief Executive Dr. Roger Mcintyre was pleased with the revocation further adding the company is geared towards advancing its business strategy to serve mental illness patients better.
“We are pleased to be moving forward with a strengthened team and focus on governance. We have successfully advanced our business strategy to establish a network of clinics designed to provide rapid-acting treatments for adults with depression,” said the CEO.